Celestica Inc. CLS
| Analyste |
Entreprise |
Prix lors de l'analyse |
Prix cible |
Gain potentiel |
Date de publication |
| Paul Treiber |
RBC Capital |
360.158 $ |
440 $ |
79.84 % |
29/04/2026 |
| Tim Long |
Barclays |
361.71 $ |
441 $ |
79.29 % |
29/04/2026 |
| Ruben Roy |
Stifel Nicolaus |
361.71 $ |
445 $ |
83.29 % |
28/04/2026 |
| Todd Coupland |
CIBC |
267.23 $ |
360 $ |
92.77 % |
11/03/2026 |
| Michael Ng |
Goldman Sachs |
326.45 $ |
440 $ |
113.55 % |
29/10/2025 |
| Tim Long |
Barclays |
326.45 $ |
357 $ |
30.55 % |
29/10/2025 |
| Paul Treiber |
RBC Capital |
264.69 $ |
315 $ |
50.31 % |
22/10/2025 |
| Ruben Roy |
Stifel Nicolaus |
120.88 $ |
140 $ |
19.12 % |
03/02/2025 |
| Paul Treiber |
RBC Capital |
123.47 $ |
140 $ |
16.53 % |
31/01/2025 |
| Thanos Moschopoulos |
BMO Capital |
66.508 $ |
72 $ |
5.49 % |
24/10/2024 |
| Maxim Matushansky |
RBC Capital |
57.47 $ |
75 $ |
17.53 % |
24/10/2024 |
| Kristina Ruggeri |
Argus Research |
52.67 $ |
58 $ |
5.33 % |
26/07/2024 |
| Matthew Sheerin |
Stifel Nicolaus |
51.07 $ |
58 $ |
6.93 % |
26/07/2024 |
| Robert Young |
Canaccord Genuity |
51.07 $ |
70 $ |
18.93 % |
26/07/2024 |
| Steven Fox |
US Capital Advisors |
48 $ |
60 $ |
12.00 % |
15/05/2024 |
| Matthew Sheerin |
Stifel Nicolaus |
46.99 $ |
51 $ |
4.01 % |
13/05/2024 |